← Leaderboards
Roy Morello
Univ Of Arkansas For Med Scis
$4,669,541
Attributed
$4,818,442
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $688.3K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,818,442 · 7
By mechanism
R01$2,787,822 · 2
P20$1,437,166 · 2
R03$370,102 · 2
R43$223,352 · 1
Top collaborators
- Carole L. Cramer1 shared
- David Radin1 shared
Most similar at Univ Of Arkansas For Med Scis
Same institution · by research overlap
- Maria Jose Almeida$5,489,226
- Charles A O'Brien$15,608,722
- Xiao-Dong Chen$1,304,595
Others in their field
Top investigators on “Phenotype”
- David R. Weir · University Of Michigan At Ann Arbor$239,033,262
- David Heimbrook · Leidos Biomedical Research, Inc.$213,586,034
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Richard A Gibbs · Baylor College Of Medicine$184,906,270
- James E. Gern · University Of Wisconsin-Madison$141,704,104
- Garret A Fitzgerald · University Of Pennsylvania$141,348,491
Research focus
PhenotypeTissuesSkeletalSkeletonDefectMolecularBone MassCollagenProteinsMutationMouse ModelCollagen Type IOsteogenesis ImperfectaCol1a1 GeneBoneGeneticGenesCol1a2 GeneIn VitroPost-Translational Protein ProcessingSkeletal DysplasiaPatternCartilageMember
Grant awards (20)
Lung developmental defects caused by type I collagen mutations in mouse models of osteogenesis imperfecta$380,648
R01 · FY2025 · HL · contact PI
Lung developmental defects caused by type I collagen mutations in mouse models of osteogenesis imperfecta$380,760
R01 · FY2024 · HL · contact PI
Lung developmental defects caused by type I collagen mutations in mouse models of osteogenesis imperfecta$394,118
R01 · FY2023 · HL · contact PI
Osteocytes in osteogenesis imperfecta (OI)$294,195
P20 · FY2023 · GM · contact PI
Bone Histology and Imaging$236,187
P20 · FY2022 · GM · contact PI
Bone Histology and Imaging$228,522
P20 · FY2021 · GM · contact PI
Bone Histology and Imaging$228,012
P20 · FY2020 · GM · contact PI
Primary lung defects in mouse models of osteogenesis imperfecta$75,500
R03 · FY2020 · HD · contact PI
Bone Histology and Imaging$225,875
P20 · FY2019 · GM · contact PI
Primary lung defects in mouse models of osteogenesis imperfecta$75,250
R03 · FY2019 · HD · contact PI
Bone Histology and Imaging$224,375
P20 · FY2018 · GM · contact PI
Role of the Leprecan Genes in Skeletal Formation$331,875
R01 · FY2016 · AR · contact PI
Role of the Leprecan Genes in Skeletal Formation$331,875
R01 · FY2015 · AR · contact PI
Role of the Leprecan Genes in Skeletal Formation$325,237
R01 · FY2014 · AR · contact PI
Targeted Enzyme Replacement Therapy for Rare Forms of Osteogenesis Imperfecta$223,352
R43 · FY2014 · AR
Role of the Leprecan Genes in Skeletal Formation$315,281
R01 · FY2013 · AR · contact PI
Role of the Leprecan genes in skeletal formation$328,028
R01 · FY2012 · AR · contact PI
Crtap function during skeletal homeostasis$71,114
R03 · FY2007 · AR · contact PI
Crtap function during skeletal homeostasis$73,238
R03 · FY2006 · AR · contact PI
Crtap function during skeletal homeostasis$75,000
R03 · FY2005 · AR